Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modafinil vs methylphenidate for excessive daytime sleepiness in Parkinson's disease
IRCT20220623055257N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Excessive Daytime Sleepiness (EDS) and Parkinson's disease (PD) comparing Modafinil with Methylphenidate (2 arms). Started Aug 2022; status: completed.
02
Drugs
modafinilmethylphenidate
03
Conditions
Excessive Daytime Sleepiness (EDS)Parkinson's disease (PD)
Beyond the preview
Go deeper on IRCT20220623055257N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220623055257N1.